fluorouracil has been researched along with astragaloside ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C; Rong, C; Su, Y; Wang, P; Xia, Q; Xu, D | 1 |
| Huang, C; Su, Y; Wang, M; Xia, Q; Xu, DJ; Yang, C | 1 |
2 other study(ies) available for fluorouracil and astragaloside ii
| Article | Year |
|---|---|
Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Astragalus Plant; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Drug Resistance, Multiple; Fluorouracil; Gene Expression; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; Phosphorylation; Phytotherapy; Plant Extracts; Rhodamine 123; Saponins | 2012 |
Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; Fluorouracil; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; RNA Interference; RNA, Small Interfering; Saponins; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |